KEI review of 62 COVID 19 contracts reveals 59 authorizations for non-voluntary use of third party patents under 28 USC 1498

Since the COVID 19 Pandemic began, there has been a spirited debate over patent rights, including a highly publicized 20 month debate over a proposed WTO waiver on intellectual property rights. During that time a handful of countries have taken… Continue Reading

Human Rights Council heats up during informal talks on inequality, international solidarity, and intellectual property

UPDATE: On Monday, 4 July 2022, a revised version of the Core Group’s access to medicines, vaccines, and other health products resolution (A/HRC/50/L.13) was circulated. The current co-sponsors include: Argentina, Brazil, China, Ecuador,* Egypt,* India, Indonesia, Malaysia, Namibia, Nepal, Paraguay,… Continue Reading

Constituency statement for Knowledge Ecology International, Health Action International, Oxfam, and Public Services International: Strengthening WHO preparedness for and response to health emergencies

On 24 May 2022, I delivered the following constituency statement on behalf of Knowledge Ecology International, Health Action International, Oxfam, and Public Services International on the following topic: “16.2 – Strengthening WHO preparedness for and response to health emergencies” at… Continue Reading

SCCR 42: KEI Statement on a proposal by the African Group for a Draft work Program on Exceptions and Limitations

On Wednesday, 11 May 2022, Knowledge Ecology International (KEI) delivered the following statement on a proposal by the African Group for a Draft work Program on Exceptions and Limitations. Knowledge Ecology International supports the Proposal by the African Group for… Continue Reading

Save the Date – 27 April 2022 – South Centre/KEI/PIJIP Workshop on the L&E work programme and the WIPO broadcasting treaty

On Wednesday, 27 April 2022 from 14:00 CEST to 16:00 CEST, the South Centre, Knowledge Ecology International (KEI), and the Washington College of Law’s Program on Information Justice and Intellectual Property (PIJIP) will convene a workshop to prepare for the… Continue Reading

Pfizer’s March 18, 2022 opposition to the KEI request for a compulsory license in Dominican Republic for Paxlovid.

On March 18, 2022, Pfizer filed a 45 page opposition to the KEI application for a compulsory license on Paxlovid patents in the Dominican Republican. This is the Pfizer filing, and KEI’s unofficial translation. Pfizer-opposition-DR-CL-18March2022.pdf Translation-Pfizer-opposition-KEI-CL-Paxlovid-18march2022.pdf The December 3, 2021… Continue Reading

Selected NIH emails from FOIA requests

2016-Mar25-email-Re-Dir-Sig-Response-March-In-Letter 2016-Dec18-Email-Chain-Re-Reasonable-Pricing-Clauses 2016-Dec24-Email-Seeking-Help-Re-NCI-Criticism-Response 2016-Dec25-Email-Seeking-Help-NCI-Rebuttal 2016Mar30-Email-Sen-Sanders-Letter 2016Apr26-Email-Nader-Response 2016Jun27-Email-re-March-in Process 2017-Jan3-Email-Re-Help-NCI-Rebuttal 2017Jan5-Email-Regarding-Kite-License-Applicants 2017Apr24-Email-Chain-Re-Xtandi-Appeal 2017Nov20-email-helping-Allen 2017-Dec7-Email-Re-Placing-Op-Ed 2019Apr16-email-CAR T-information